Clinical relevance and virulence factors of pigmented Serratia marcescens.

Pigmented Serratia marcescens isolated in a Brazilian hospital were studied with respect to frequency of isolation, serotyping, antibiotic resistance and virulence factors. The serotype most frequent was O6:K14 (53%) and all isolates were resistant to ampicillin, cephalothin and tetracycline. The majority of the isolates (92%) were resistant to the action of human serum and all produced cytotoxins on Vero, CHO, HEp-2 and HeLa cells. These isolates were virulent for mice (LD(50)=10(7) bacteria ml(-1)) and showed virulence factors, but were isolated with low frequency (3. 4%) and caused infection in only 31% of cases. Analysis of serotyping, phage typing and chromosomal DNA revealed at least 13 unrelated strains among pigmented S. marcescens. In conclusion, this work describes a low frequency of isolation of pigmented S. marcescens from clinical specimens, indicating that non-pigmented strains are clinically more significant.

[1]  T. Pitt,et al.  Antibiotic resistance and putative virulence factors of Serratia marcescens with respect to O and K serotypes. , 1998, Journal of medical microbiology.

[2]  T. Pitt,et al.  Different O and K serotype distributions among clinical and environmental strains of Serratia marcescens. , 1998, Journal of medical microbiology.

[3]  A. Hejazi,et al.  The use of RAPD-PCR as a typing method for Serratia marcescens. , 1997, Journal of medical microbiology.

[4]  R. Gautom.  Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day , 1997, Journal of clinical microbiology.

[5]  A. L. Darini,et al.  Detection of cytotoxic activity on Vero cells in clinical isolates of Serratia marcescens. , 1997, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[6]  A. L. Darini,et al.  [Plasmid size determination using 3 methods]. , 1995, Revista latinoamericana de microbiologia.

[7]  B. Finlay,et al.  Common themes in microbial pathogenicity , 1989, Microbiological reviews.

[8]  D. Gargallo‐Viola.  Enzyme polymorphism, prodigiosin production, and plasmid fingerprints in clinical and naturally occurring isolates of Serratia marcescens , 1989, Journal of clinical microbiology.

[9]  Charles W. Stratton.  Pseudomonas aeruginosa , 1983, Infection Control.

[10]  S. T. Liu,et al.  Rapid procedure for detection and isolation of large and small plasmids , 1981, Journal of bacteriology.

[11]  T. Pitt,et al.  The epidemiological type identification of Serratia marcescens from outbreaks of infection in hospitals , 1980, Journal of Hygiene.

[12]  J Konowalchuk,et al.  Vero response to a cytotoxin of Escherichia coli , 1977, Infection and immunity.

[13]  R. P. Williams.  Biosynthesis of prodigiosin, a secondary metabolite of Serratia marcescens. , 1973, Applied microbiology.

[14]  R. P. Williams,et al.  Influence of Temperature of Incubation and Type of Growth Medium on Pigmentation in Serratia marcescens , 1971, Journal of bacteriology.

[15]  M. Finland,et al.  Serratia marcescens: Biochemical, Serological, and Epidemiological Characteristics and Antibiotic Susceptibility of Strains Isolated at Boston City Hospital , 1970, Applied microbiology.

[16]  A. Bauer,et al.  Antibiotic susceptibility testing by a standardized single disk method. , 1966, American journal of clinical pathology.

[17]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .

[18]  R. P. Williams,et al.  Amino acids , 2006 .